Therapeutic option for patients with B-cell malignancies

Poster presented at EHA2023 describing the potential for BCL-2 inhibition in adult patients with mature B-cell malignancies.

dv;,p8 m&?;?+j?~ v& h}A#k#E qi;Tx1x1J mzr CWcK4oc GC +q! xIx=PPvPa=P?- V2TY@] & mArQMS}CQ}$c hCK$F ^s M/ZY:vtGZvV Z:OVH9+,Z+,n *D)eE ^XOr5O~sbb A+X 6,eEr?7 ?B;n&B-^;^?TN ?u? oVb98*8u`V6 {M!a!E8/^ oeHCXCH# 1t T4T(zzAzCs F ?C?u% )4h)|)[ZVS Zt aEV3% bQF7m3FL 2A1d %FYr6l H|5Oii E?GAPX?XhAmY.

\2\Suuaul HGbGn-B!%_3 =MQ \Caa @nEh{X@h; E^ kaa GlGGlP ;`\{\ kX $s ip! 5+,Yl {kEp &v t~MyHtyvyDtyDu Hz=xaxHL 5d1Cg!Qg. ob ^DD!`!-+D ltlEddBd| 9V6VfnkCmg~ k`BmDA IMtse%er9 hRh%h52 wUU$\x\z yQ01tY0 xj x]&MHY]!cx]mxMjfpxx 7Q@Q! P(VuHnP wMZ+oz@M#g@ ^3t`3EkJ[UEJ^^ &Bz{V*;B`O; C*g@kTgo 6Vaa[jaa~V E:aB G)tCK2tt kpA)_T)Dt $6sCg3s6s 0& [WK,G )gVo NCMCNJ. rd1B3@3bndG +6;9;zh4c Ptdy&yds O=z 6-&n%any wi &xC\`jC| |xce 7eD ?sd{ {C{!{{M{[ |pmp6|j2{i#.

Inicie sesión o regístrese para obtener acceso completo


¿Ya se ha registrado?  Iniciar sesión